Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,966
Total Claims
$311K
Drug Cost
668
Beneficiaries
$466
Cost/Patient
Risk Score Breakdown 49/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1569%
Opioid rate vs peers
63.1% vs 3.8% avg
-60%
Cost per patient vs peers
$466 vs $1,174 avg
-58%
Brand preference vs peers
3.7% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
63.1%
Opioid Rate
3,765
Opioid Claims
$207K
Opioid Cost
11.2%
Long-Acting Rate
This provider's opioid prescribing rate of 63.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 222 claims · $87K
Generic: 5,744 claims · $224K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 1,077 | $67K |
| Hydrocodone/Acetaminophen | 1,103 | $42K |
| Rimegepant Sulfate | 16 | $29K |
| Fentanyl | 235 | $27K |
| Oxycodone Myristate | 30 | $19K |
| Oxycodone Hcl | 527 | $17K |
| Linaclotide | 28 | $16K |
| Erenumab-Aooe | 14 | $11K |
| Gabapentin | 565 | $9,900 |
| Hydromorphone Hcl | 385 | $9,843 |
| Pregabalin | 272 | $7,160 |
| Morphine Sulfate | 113 | $6,782 |
| Hydrocodone/Ibuprofen | 15 | $5,436 |
| Baclofen | 188 | $4,614 |
| Carisoprodol | 142 | $2,513 |
Prescribing Profile
30
Unique Drugs
49.0
Anomaly Score
Patient Profile
68
Avg Age
64%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About